Danaher Corporation [NYSE: DHR] gained 2.42% on the last trading session, reaching $226.06 price per share at the time. The company report on October 9, 2020 that Beckman Coulter SARS-CoV-2 IgM Antibody Test Receives FDA Emergency Use Authorization.
Beckman Coulter, a clinical diagnostics leader, today announced its Access SARS-CoV-2 Immunoglobulin M (IgM) assay has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). The assay detects antibodies that recognize the receptor binding domain (RBD) of the spike protein which the SARS-CoV-2 virus uses to enter the human host cells. The assay, which demonstrates 99.9% specificity and 98.3% sensitivity, is part of a suite of diagnostic solutions being developed by Beckman Coulter in response to the ongoing COVID-19 pandemic to guide physicians and patients in their healthcare decision making.
Beckman Coulter’s Access SARS-CoV-2 IgM antibody assay receives Emergency Use Authorization from the U.S. FDA.
Danaher Corporation represents 705.10 million in outstanding shares, while the company has a total market value of $156.57 billion with the latest information. DHR stock price has been found in the range of $221.17 to $226.17.
If compared to the average trading volume of 2.07M shares, DHR reached a trading volume of 1618126 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Danaher Corporation [DHR]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for DHR shares is $223.93 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on DHR stock is a recommendation set at 1.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wolfe Research have made an estimate for Danaher Corporation shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on June 16, 2020. The new note on the price target was released on April 02, 2020, representing the official price target for Danaher Corporation stock. Previously, the target price had yet another raise from $151 to $157, while RBC Capital Mkts kept a Outperform rating on DHR stock. On February 03, 2020, analysts increased their price target for DHR shares from 167 to 187.
The Average True Range (ATR) for Danaher Corporation is set at 4.60, with the Price to Sales ratio for DHR stock in the period of the last 12 months amounting to 8.94. The Price to Book ratio for the last quarter was 4.83, with the Price to Cash per share for the same quarter was set at 8.00. Price to Free Cash Flow for DHR in the course of the last twelve months was 49.27 with Quick ratio for the last quarter at 1.70.
Trading performance analysis for DHR stock
Danaher Corporation [DHR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 6.38. With this latest performance, DHR shares gained by 11.31% in over the last four-week period, additionally plugging by 54.70% over the last 6 months – not to mention a rise of 62.91% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for DHR stock in for the last two-week period is set at 72.53, with the RSI for the last a single of trading hit 77.96, and the three-weeks RSI is set at 69.67 for Danaher Corporation [DHR]. The present Moving Average for the last 50 days of trading for this stock 207.61, while it was recorded at 221.08 for the last single week of trading, and 173.04 for the last 200 days.
Danaher Corporation [DHR]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Danaher Corporation [DHR] shares currently have an operating margin of +18.77 and a Gross Margin at +55.74. Danaher Corporation’s Net Margin is presently recorded at +13.58.
Return on Total Capital for DHR is now 7.41, given the latest momentum, and Return on Invested Capital for the company is 5.39. Return on Equity for this stock inclined to 8.32, with Return on Assets sitting at 4.43. When it comes to the capital structure of this company, Danaher Corporation [DHR] has a Total Debt to Total Equity ratio set at 74.42. Additionally, DHR Total Debt to Total Capital is recorded at 42.67, with Total Debt to Total Assets ending up at 36.28. Long-Term Debt to Equity for the company is recorded at 77.28, with the Long-Term Debt to Total Capital now at 41.96.
Reflecting on the efficiency of the workforce at the company, Danaher Corporation [DHR] managed to generate an average of $40,538 per employee. Receivables Turnover for the company is 5.30 with a Total Asset Turnover recorded at a value of 0.33.Danaher Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.70 and a Current Ratio set at 2.20.
Danaher Corporation [DHR]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Danaher Corporation posted 1.06/share EPS, while the average EPS was predicted by analysts to be reported at 1.15/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -7.80%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for DHR. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Danaher Corporation go to 13.06%.
An analysis of insider ownership at Danaher Corporation [DHR]
There are presently around $126,875 million, or 81.60% of DHR stock, in the hands of institutional investors. The top three institutional holders of DHR stocks are: VANGUARD GROUP INC with ownership of 49,729,454, which is approximately -2.302% of the company’s market cap and around 0.50% of the total institutional ownership; BLACKROCK INC., holding 45,089,961 shares of the stock with an approximate value of $10.19 billion in DHR stocks shares; and PRICE T ROWE ASSOCIATES INC /MD/, currently with $8.49 billion in DHR stock with ownership of nearly -5.259% of the company’s market capitalization.
Positions in Danaher Corporation stocks held by institutional investors increased at the end of July and at the time of the July reporting period, where 727 institutional holders increased their position in Danaher Corporation [NYSE:DHR] by around 32,736,560 shares. Additionally, 710 investors decreased positions by around 24,437,397 shares, while 208 investors held positions by with 504,070,550 shares. The mentioned changes placed institutional holdings at 561,244,507 shares, according to the latest SEC report filing. DHR stock had 167 new institutional investments in for a total of 4,386,481 shares, while 86 institutional investors sold positions of 1,030,043 shares during the same period.